$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks. Here are some top stocks in the sector climbing on drug trial and earnings news: $Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap. $Ligand Pharmaceuticals (LGND.US)$gained 23%...
The market's expectation of a decline in future revenue performance could be keeping BeiGene's P/S ratio low. Despite potential for share price to match revenue if current course is maintained, the company's inferior revenue outlook may suggest limited future growth to investors.
$恒生指數(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$榮昌生物(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $三葉草生物-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$維亞生物(01873.HK)$...
SpyderCall : 像往常一樣非常有價值的信息。謝謝你的辛勤工作
shintaka1168 : 他們分發這種信息真令人驚訝。我想我會再次檢查